Literature DB >> 27015018

Staphylococcus aureus β-Toxin Mutants Are Defective in Biofilm Ligase and Sphingomyelinase Activity, and Causation of Infective Endocarditis and Sepsis.

Alfa Herrera1, Bao G Vu1, Christopher S Stach1, Joseph A Merriman1, Alexander R Horswill1, Wilmara Salgado-Pabón1, Patrick M Schlievert1.   

Abstract

β-Toxin is an important virulence factor of Staphylococcus aureus, contributing to colonization and development of disease [Salgado-Pabon, W., et al. (2014) J. Infect. Dis. 210, 784-792; Huseby, M. J., et al. (2010) Proc. Natl. Acad. Sci. U.S.A. 107, 14407-14412; Katayama, Y., et al. (2013) J. Bacteriol. 195, 1194-1203]. This cytotoxin has two distinct mechanisms of action: sphingomyelinase activity and DNA biofilm ligase activity. However, the distinct mechanism that is most important for its role in infective endocarditis is unknown. We characterized the active site of β-toxin DNA biofilm ligase activity by examining deficiencies in site-directed mutants through in vitro DNA precipitation and biofilm formation assays. Possible conformational changes in mutant structure compared to that of wild-type toxin were assessed preliminarily by trypsin digestion analysis, retention of sphingomyelinase activity, and predicted structures based on the native toxin structure. We addressed the contribution of each mechanism of action to producing infective endocarditis and sepsis in vivo in a rabbit model. The H289N β-toxin mutant, lacking sphingomyelinase activity, exhibited lower sepsis lethality and infective endocarditis vegetation formation compared to those of the wild-type toxin. β-Toxin mutants with disrupted biofilm ligase activity did not exhibit decreased sepsis lethality but were deficient in infective endocarditis vegetation formation compared to the wild-type protein. Our study begins to characterize the DNA biofilm ligase active site of β-toxin and suggests β-toxin functions importantly in infective endocarditis through both of its mechanisms of action.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27015018      PMCID: PMC5312681          DOI: 10.1021/acs.biochem.6b00083

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

Review 1.  Toxic shock syndrome and bacterial superantigens: an update.

Authors:  J K McCormick; J M Yarwood; P M Schlievert
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

2.  Pathology and pathogenesis of infective endocarditis in native heart valves.

Authors:  Gaetano Thiene; Cristina Basso
Journal:  Cardiovasc Pathol       Date:  2006 Sep-Oct       Impact factor: 2.185

3.  Selective killing of human monocytes and cytokine release provoked by sphingomyelinase (beta-toxin) of Staphylococcus aureus.

Authors:  I Walev; U Weller; S Strauch; T Foster; S Bhakdi
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

Review 4.  Clinical practice. Infective endocarditis.

Authors:  Bruno Hoen; Xavier Duval
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245

Review 5.  Sphingolipid mediators in cardiovascular cell biology and pathology.

Authors:  T Levade; N Augé; R J Veldman; O Cuvillier; A Nègre-Salvayre; R Salvayre
Journal:  Circ Res       Date:  2001-11-23       Impact factor: 17.367

Review 6.  Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Imad M Tleyjeh; Michael J Rybak; Bruno Barsic; Peter B Lockhart; Michael H Gewitz; Matthew E Levison; Ann F Bolger; James M Steckelberg; Robert S Baltimore; Anne M Fink; Patrick O'Gara; Kathryn A Taubert
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

7.  Staphylococcus aureus endocarditis: a consequence of medical progress.

Authors:  Vance G Fowler; Jose M Miro; Bruno Hoen; Christopher H Cabell; Elias Abrutyn; Ethan Rubinstein; G Ralph Corey; Denis Spelman; Suzanne F Bradley; Bruno Barsic; Paul A Pappas; Kevin J Anstrom; Dannah Wray; Claudio Q Fortes; Ignasi Anguera; Eugene Athan; Philip Jones; Jan T M van der Meer; Tom S J Elliott; Donald P Levine; Arnold S Bayer
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

8.  Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms.

Authors:  Medora J Huseby; Andrew C Kruse; Jeff Digre; Petra L Kohler; Jillian A Vocke; Ethan E Mann; Kenneth W Bayles; Gregory A Bohach; Patrick M Schlievert; Douglas H Ohlendorf; Cathleen A Earhart
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

9.  Alpha and beta chains of hemoglobin inhibit production of Staphylococcus aureus exotoxins.

Authors:  Patrick M Schlievert; Laura C Case; Kimberly A Nemeth; Catherine C Davis; Yiping Sun; Wendy Qin; Fancheng Wang; Amanda J Brosnahan; John A Mleziva; Marnie L Peterson; Bruce E Jones
Journal:  Biochemistry       Date:  2007-11-20       Impact factor: 3.162

10.  Staphylococcus aureus β-toxin production is common in strains with the β-toxin gene inactivated by bacteriophage.

Authors:  Wilmara Salgado-Pabón; Alfa Herrera; Bao G Vu; Christopher S Stach; Joseph A Merriman; Adam R Spaulding; Patrick M Schlievert
Journal:  J Infect Dis       Date:  2014-03-11       Impact factor: 5.226

View more
  12 in total

Review 1.  Group II Intron RNPs and Reverse Transcriptases: From Retroelements to Research Tools.

Authors:  Marlene Belfort; Alan M Lambowitz
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-04-01       Impact factor: 10.005

2.  Commensal Staphylococcus epidermidis contributes to skin barrier homeostasis by generating protective ceramides.

Authors:  Yue Zheng; Rachelle L Hunt; Amer E Villaruz; Emilie L Fisher; Ryan Liu; Qian Liu; Gordon Y C Cheung; Min Li; Michael Otto
Journal:  Cell Host Microbe       Date:  2022-02-04       Impact factor: 21.023

3.  Label-free electrochemical biosensor for determination of procalcitonin based on graphene-wrapped Co nanoparticles encapsulated in carbon nanobrushes coupled with AuPtCu nanodendrites.

Authors:  Xin-Yue Ge; Jing-Xian Zhang; Yi-Ge Feng; Ai-Jun Wang; Li-Ping Mei; Jiu-Ju Feng
Journal:  Mikrochim Acta       Date:  2022-02-17       Impact factor: 5.833

4.  Bacterial Sphingomyelinase is a State-Dependent Inhibitor of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR).

Authors:  B B Stauffer; G Cui; K A Cottrill; D T Infield; N A McCarty
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

5.  Staphylococcal β-Toxin Modulates Human Aortic Endothelial Cell and Platelet Function through Sphingomyelinase and Biofilm Ligase Activities.

Authors:  Alfa Herrera; Katarina Kulhankova; Vijay K Sonkar; Sanjana Dayal; Aloysius J Klingelhutz; Wilmara Salgado-Pabón; Patrick M Schlievert
Journal:  MBio       Date:  2017-03-21       Impact factor: 7.867

6.  ϕSa3mw Prophage as a Molecular Regulatory Switch of Staphylococcus aureus β-Toxin Production.

Authors:  Phuong M Tran; Michael Feiss; Kyle J Kinney; Wilmara Salgado-Pabón
Journal:  J Bacteriol       Date:  2019-06-21       Impact factor: 3.490

7.  Staphylococcus aureus β-Hemolysin Up-Regulates the Expression of IFN-γ by Human CD56bright NK Cells.

Authors:  Zhangchun Guan; Yu Liu; Chenghua Liu; Huiting Wang; Jiannan Feng; Guang Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-29       Impact factor: 5.293

Review 8.  Epidemiology and Pathogenesis of Staphylococcus Bloodstream Infections in Humans: a Review.

Authors:  Klaudia Lisowska-Łysiak; Ryszard Lauterbach; Jacek Międzobrodzki; Maja Kosecka-Strojek
Journal:  Pol J Microbiol       Date:  2021-02-24

Review 9.  Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia.

Authors:  Jelle Vlaeminck; Dina Raafat; Kristin Surmann; Leen Timbermont; Nicole Normann; Bret Sellman; Willem J B van Wamel; Surbhi Malhotra-Kumar
Journal:  Toxins (Basel)       Date:  2020-11-18       Impact factor: 4.546

Review 10.  Anti-biofilm Approach in Infective Endocarditis Exposes New Treatment Strategies for Improved Outcome.

Authors:  Christian Johann Lerche; Franziska Schwartz; Marie Theut; Emil Loldrup Fosbøl; Kasper Iversen; Henning Bundgaard; Niels Høiby; Claus Moser
Journal:  Front Cell Dev Biol       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.